Billiver

Find a company

Search the 63 companies in this collection.

63 companies found

Arrow keys to choose · Enter to open · Escape to close
COMPANY FILINGS

Nordson

NDSN

In fiscal 2025, Nordson manufactured precision dispensing, fluid-control and quality-inspection products for medical, electronics, industrial and other end markets.

Business description: FY2025CIK 0000072331Source: SEC EDGAR
Annual reports
5
Report coverage
2021–2025
Financial statement focus
Balance sheet
READ THE FILING

Annual report insights

AI summary

AI-generated summaries of the cited 10-K filings. For informational purposes only; not personalized investment advice.

Choose a fiscal year

Fiscal 2025

Year ended Filed

Read FY2025 annual report (opens in a new tab)

  • Fiscal 2025 consolidated sales increased 3.8% from fiscal 2024, despite a 2.5% decline in organic sales, which exclude acquisition/divestiture and currency effects.

    Source: 2025

  • Nordson sold selected medical contract manufacturing product lines on September 2, 2025. As part of its exit from that business, it also announced plans to close its remaining medical contract manufacturing facility; the disclosure does not establish that the closure was completed.

    Source: 2025
View full 10-K summary 2025Hide full 10-K summary 2025

Signals describe observations in the selected filing, not forecasts or investment ratings. Risk disclosures do not establish that a loss occurred.

Positive signals

  • Electronics sales

    Advanced Technology Solutions organic sales increased 4.1% in fiscal 2025 versus fiscal 2024. Management attributed the increase to growth in electronics dispensing, electronic processing and optical sensors, partially offset by weakness in x-ray inspection systems.

    Source: 2025

Negative signals

  • Interest expense

    Interest expense increased 17.1% in fiscal 2025 from fiscal 2024. Management attributed the increase to higher average debt levels resulting from acquisition funding.

    Source: 2025

Business context

  • Trade-policy risk

    Separately from its realized fiscal 2025 results, Nordson warned that changes in trade policies, tariffs and import/export regulations could reduce operating cash flow and liquidity in future periods.

    Source: 2025

Business in fiscal 2025

In fiscal 2025, Nordson manufactured precision dispensing, fluid-control and quality-inspection products for medical, electronics, industrial and other end markets.

Source: 2025

5-year changes

FY2021–FY2025

These changes use selected original filing passages and nearby context from the stated five fiscal years. They are not an exhaustive review of all five reports and exclude later-year filings.

  • Supply conditions

    In fiscal 2021, Nordson reported logistics constraints, higher freight rates and difficulty obtaining selected manufacturing components. In fiscal 2023, it reported supply-chain stabilization and improved lead times. In fiscal 2025, it described improved logistics and forwarding rates closer to pre-pandemic levels, but Asia-origin shipments remained more volatile and parcel and domestic trucking rates continued to rise moderately.

    Source: 2021, 2023, 2025
  • Sales changes

    Nordson reported 10.8% organic sales growth in fiscal 2022 versus fiscal 2021, including price increases to offset inflation. Organic sales exclude acquisition/divestiture and currency effects. In fiscal 2025 versus fiscal 2024, organic sales declined 2.5%, although consolidated sales increased 3.8%. These comparisons show different growth conditions, not a continuous annual trend.

    Source: 2022, 2025
  • Medical business changes

    Nordson acquired Atrion on August 21, 2024, adding medical infusion fluid-delivery and niche cardiovascular solutions to its Medical and Fluid Solutions segment. In fiscal 2025, it announced plans to close its remaining medical contract manufacturing facility and completed the sale of selected contract manufacturing product lines within that segment on September 2. The facility closure was disclosed as planned, not completed.

    Source: 2024, 2025
Request a correction

This request covers the entire NDSN FY2025 summary, including the 5-year comparison.

We keep your message and the summary version as a record of our review and any correction. Personal information included in a message is removed during review. Please do not include personal details, passwords or private URLs. Your message is not published. Requests are stored privately with our database provider. Hosting and security providers may process technical data such as IP addresses. Removal applies to the application record; provider backups and security logs follow their retention rules.

FINANCIAL STATEMENTS

Balance sheet

A snapshot of what Nordson owns and owes at a point in time.

The original comes first.

Read the company’s balance sheet in the original annual reports below.

Browse original filings
Assets
What the company owns
Liabilities
What the company owes
Equity
Assets less liabilities

See the original statement for its reporting period, currency, and unit.

SOURCE LIBRARY

Annual reports & SEC 10-K filings

SEC EDGAR

5 reports in this collection

Original SEC annual reports, with report period and filing date
Report periodFiled with SECFormSource
Oct 31, 20250000072331-25-000144Dec 17, 202510-KOpen 10-Ksec.govRead FY2025 summary
Oct 31, 20240000072331-24-000177Dec 18, 202410-KOpen 10-Ksec.gov
Oct 31, 20230000072331-23-000242Dec 20, 202310-KOpen 10-Ksec.gov
Oct 31, 20220000072331-22-000185Dec 19, 202210-KOpen 10-Ksec.gov
Oct 31, 20210000072331-21-000079Dec 17, 202110-KOpen 10-Ksec.gov

Dates describe the filing metadata. Figures and reporting periods should be checked against the original statement. SEC links open in a new tab.